Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma. The acceleration of adoption of tumor profiling into routine clinical practice: An insight from review of the ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

The ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been caused by the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly affected the ...

Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?

Overreliance on D-dimer testing and similarity to other conditions may mean pulmonary embolism or venous thromboembolism is ...

Venous thromboembolism (VTE) is a common disease that affects as many as 900,000 Americans yearly with an estimated 60,000 - 100,000 Americans dying each year as a result of VTE. D-Dimer levels ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...